NUVA up +2.59% percent right now. $NUVA High is at 44.50

New Post Public Reply Private Reply Replies (0) Message Board

Nov 11, 2014 at 2:02 PM

NUVA up +2.59% percent right now. $NUVA High is at 44.50 and the Low 42.46 with current volume of 247,170.

Recent News posted below.

NUVA Nuvasive Inc Recent Headline News

NuVasive(R) Focused on Surgeon Support and Showcasing Industry-Leading Products at North American Spine Society 29th Annual Meeting
Marketwired - Mon Nov 10, 3:07PM CST
NuVasive, Inc. (NASDAQ: NUVA) ("NuVasive or the "Company"

, a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, today announced that it will attend the 29th North American Spine Society ("NASS"

Annual Meeting, held November 12-15, 2014, at the Moscone Center in San Francisco, CA. The Company's attendance underscores NuVasive's ongoing commitment to surgeon support through numerous educational workshops and the exhibition of several of the Company's products and procedures that have revolutionized the spine industry.
NUVA: 43.24 (+0.77)

NuVasive Has Returned 18.5% Since SmarTrend Recommendation (NUVA)
Comtex SmarTrend(R) - Mon Nov 10, 12:55PM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on June 23rd, 2014 at $35.67. In approximately 5 months, NuVasive has returned 18.46% as of today's recent price of $42.25.
NUVA: 43.24 (+0.77)

NuVasive Earnings Hindsight: Up 6.3% in Last 11 Days (NUVA)
Comtex SmarTrend(R) - Mon Nov 10, 11:41AM CST
11 days ago, on October 30th, 2014, NuVasive (NASDAQ:NUVA) reported its earnings. Analysts, on average, expected earnings of $0.25 per share on sales of $179.1 million. NuVasive actually reported earnings of $0.19 per share on sales of $189.9 million, missing EPS estimates by $0.06 and beating revenue estimates by $10.9 million. Since the company's report, shares of NuVasive have risen from $39.26 to $41.75, representing a gain of 6.3% in the past 11 days.
NUVA: 43.24 (+0.77)

Could This Obamacare Tax Be Repealed?
Sean Williams, The Motley Fool - Motley Fool - Sun Nov 09, 7:18AM CST
Source: White House on Flickr. With the midterm elections now in the rear-view mirror, Americans can begin speculating about the policies that will come out of Washington over the next two years. Personally, I can't say I'm a huge fan of the...
ZMH: 111.05 (+0.63), BSX: 13.36 (-0.09), MDT: 68.84 (+0.13), NUVA: 43.24 (+0.77)

Update: NuVasive Q3 2014 Earnings
Andy Batts - at Seeking Alpha - Fri Nov 07, 3:09PM CST

NUVA: 43.24 (+0.77)

Insider Trading Alert - SANM, NUVA And EMC Traded By Insiders
at The Street - Wed Nov 05, 10:24AM CST
Stocks with insider trader activity include SANM, NUVA and EMC
EMC: 29.06 (-0.10), NUVA: 43.24 (+0.77), SANM: 25.59 (+0.20)

Republicans Grab Senate: Which Stocks Will Fare Well? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:19AM CST
The Republican win will certainly bolster stocks and give investors more chances to earn.
GD: 141.19 (+0.37), LMT: 186.96 (-0.03), MDT: 68.84 (+0.13), QDEL: 28.10 (+0.08), XOM: 96.35 (+0.07), CLF: 10.82 (-0.22), BA: 125.35 (+0.71), NUVA: 43.24 (+0.77), ANR: 2.62 (-0.02), BSX: 13.36 (-0.09), VLO: 51.22 (+0.63), BTU: 11.15 (-0.25), ABAX: 53.35 (+0.41), IMO: 47.65 (+0.15), ACI: 2.42 (-0.09)

NuVasive to Host Investor Morning on November 13, 2014
Marketwired - Mon Nov 03, 3:09PM CST
NuVasive, Inc. (NASDAQ: NUVA) ("NuVasive" or the "Company"

, a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that it will host a meeting for investors and analysts on Thursday, November 13, 2014 from 8:00 a.m. to 10:00 a.m. PT at the W Hotel in San Francisco, California.
NUVA: 43.24 (+0.77)

NuVasive Shares Up 16.2% Since SmarTrend's Buy Recommendation (NUVA)
Comtex SmarTrend(R) - Mon Nov 03, 9:57AM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on June 23rd, 2014 at $35.67. In approximately 4 months, NuVasive has returned 16.22% as of today's recent price of $41.45.
NUVA: 43.24 (+0.77)

NuVasive spikes 3.8% after guidance update
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 3:15PM CDT

NUVA: 43.24 (+0.77)

NuVasive's (NUVA) CEO Alex Lukianov on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Oct 31, 12:15AM CDT

NUVA: 43.24 (+0.77)

NuVasive (NUVA) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 4:25PM CDT

NUVA: 43.24 (+0.77)

NuVasive misses by $0.06, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 3:43PM CDT

NUVA: 43.24 (+0.77)

NuVasive Reports Third Quarter 2014 Financial Results and Increases Full Year Guidance
Marketwired - Thu Oct 30, 3:07PM CDT
NuVasive, Inc. (NASDAQ: NUVA)
NUVA: 43.24 (+0.77)

NuVasive Announces Conference Call and Webcast of Third Quarter 2014 Results
Marketwired - Thu Oct 16, 3:30PM CDT
NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that its third quarter 2014 earnings announcement will take place on Thursday, October 30, 2014, after the close of the market.
NUVA: 43.24 (+0.77)

Insider Trading Alert - REX, NVAX And NUVA Traded By Insiders
at The Street - Tue Oct 07, 10:54AM CDT
Stocks with insider trader activity include REX, NVAX and NUVA
NVAX: 5.34 (+0.13), REX: 69.52 (-1.62), NUVA: 43.24 (+0.77)

NuVasive(R) Demonstrates Expanding EMEA Business at Eurospine 2014 With Surgeon Workshops and Innovative Product Exhibition
Thomson Reuters ONE - Wed Oct 01, 7:31AM CDT
Product Demonstrations and Spine Procedure Workshops Highlight Commitment to Serving the Needs of Patients and Surgeons in Europe; Company Also Announces Opening of New European Center of Excellence in Amsterdam
NUVA: 43.24 (+0.77)

Will This Analyst Upgrade Help NuVasive (NUVA) Stock Today?
at The Street - Tue Sep 30, 8:31AM CDT
Brean Capital upgraded NuVasive (NUVA) to 'buy' from 'hold' and set a $44 price target.
NUVA: 43.24 (+0.77)

Upgrade Alert for NuVasive (NUVA)
Comtex SmarTrend(R) - Tue Sep 30, 7:07AM CDT
NuVasive (NASDAQ:NUVA) was upgraded from Hold to Buy at Brean Capital today. The stock closed yesterday at $35.02 on volume of 139,000 shares, below average daily volume of 256,000. NuVasive, Inc. designs, develops, and markets products for the surgical treatment of spine disorders. The Company's products include Maximum Access Surgery (MAS) and Fusion products.
NUVA: 43.24 (+0.77)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Aluminum Design Fumble: Geometry Over Wall Thickness

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

What to Expect: Your First Therapy Session Insights

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Darden Faces Class Action Over Reimbursement Failures

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Bio-Thera's New Data: A Game Changer for NSCLC?

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Master Sommeliers and Italian Producers Clash on Wine Lists

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

CapCut's AI Tools Reshape Video Content Creation

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...